2014		2015		2016		Rate(Cases per 100,000 per quarter)		Quarterly Rate Comparison
Disease	Q1 No.	YTD No.	Q1 No.	YTD No.	Q1 No.	YTD No.	Qtr1 (2011-2015 aggregated)	Qtr1 (2016)	Significant change bet. current & past 5-year?~~
VACCINE PREVENTABLE
DIPHTHERIA	0	0	0	0	0	0	0.00	0.00
HAEMOPHILUS INFLUENZA (INVASIVE)	.	.	5	5	7	7	0.22	0.33
HEPATITIS A	.	.	.	.	.	.	0.10	0.09
HEPATITIS B (ACUTE)	.	.	.	.	.	.	0.31	0.05
INFLUENZA**	384	384	383	383	422	422	18.30	20.00
MEASLES	0	0	9	9	0	0	0.10	0.00	X
MUMPS	0	0	0	0	0	0	0.00	0.00
PERTUSSIS	16	16	21	21	11	11	0.70	0.52
POLIOMYELITIS	0	0	0	0	0	0	0.00	0.00
RUBELLA	0	0	0	0	0	0	0.00	0.00
TETANUS	0	0	0	0	0	0	0.00	0.00
SEXUALLY TRANSMITTED
AIDS	46	46	32	32	44	44	2.40	2.09
CHLAMYDIA	2528	2528	2485	2485	2549	2549	116.59	120.80
GONORRHEA	566	566	705	705	710	710	27.23	33.65	X
HIV	54	54	65	65	84	84	3.03	3.98
SYPHILIS (EARLY LATENT)	71	71	93	93	100	100	3.24	4.74	X
SYPHILIS (PRIMARY & SECONDARY)	59	59	50	50	62	62	1.85	2.94	X
ENTERICS
AMEBIASIS	0	0	.	.	.	.	0.08	0.05
BOTULISM-INTESTINAL (INFANT)	0	0	0	0	0	0	0.00	0.00
CAMPYLOBACTERIOSIS	26	26	19	19	26	26	1.00	1.23
CHOLERA	0	0	0	0	0	0	0.00	0.00
CRYPTOSPORIDIOSIS	.	.	.	.	0	0	0.06	0.00	X
GIARDIA	6	6	8	8	7	7	0.53	0.33
ROTAVIRUS	7	7	37	37	.	.	0.95	0.14	X
SALMONELLOSIS	16	16	24	24	20	20	1.14	0.95
SHIGA-TOXIN PRODUCING E. COLI#	.	.	8	8	6	6	0.43	0.28
SHIGELLOSIS	5	5	5	5	11	11	0.27	0.52
TYPHOID FEVER	.	.	0	0	0	0	0.03	0.00
VIBRIO (NON-CHOLERA)	.	.	0	0	0	0	0.01	0.00
YERSINIOSIS	.	.	0	0	0	0	0.03	0.00
OTHER
ANTHRAX	0	0	0	0	0	0	0.00	0.00
BOTULISM INTOXICATION	0	0	0	0	0	0	0.00	0.00
BRUCELLOSIS	0	0	0	0	0	0	0.00	0.00
COCCIDIOIDOMYCOSIS	19	19	16	16	17	17	1.01	0.81
DENGUE FEVER	.	.	0	0	.	.	0.02	0.05
ENCEPHALITIS	0	0	.	.	0	0	0.02	0.00
HANTAVIRUS	0	0	0	0	0	0	0.00	0.00
HEMOLYTIC UREMIC SYNDROME (HUS)	0	0	0	0	0	0	0.00	0.00
HEPATITIS C (ACUTE)	0	0	.	.	.	.	0.09	0.14
HEPATITIS D	0	0	0	0	0	0	0.00	0.00
INVASIVE GROUP A STREP.##	0	0	0	0	0	0	0.00	0.00
LEGIONELLOSIS	.	.	8	8	.	.	0.19	0.14
LEPROSY (HANSEN’S DISEASE)	0	0	0	0	0	0	0.00	0.00
LEPTOSPIROSIS	0	0	0	0	0	0	0.00	0.00
LISTERIOSIS	0	0	.	.	0	0	0.03	0.00
LYME DISEASE	0	0	0	0	0	0	0.01	0.00
MALARIA	0	0	0	0	.	.	0.03	0.09
MENINGITIS, ASEPTIC/VIRAL	10	10	8	8	.	.	0.33	0.14
MENINGITIS, BACTERIAL	5	5	.	.	9	9	0.13	0.43
MENINGOCOCCAL DISEASE	.	.	0	0	.	.	0.05	0.14
PLAGUE	0	0	0	0	0	0	0.00	0.00
PSITTACOSIS	0	0	0	0	.	.	0.00	0.05
Q FEVER	0	0	0	0	0	0	0.00	0.00
RABIES (HUMAN)	0	0	0	0	0	0	0.00	0.00
RELAPSING FEVER	0	0	0	0	0	0	0.00	0.00
ROCKY MOUNTAIN SPOTTED FEVER	0	0	0	0	0	0	0.00	0.00
RSV (RESPIRATORY SYNCYTIAL VIRUS)	502	502	1040	1040	252	252	42.58	11.94	X
STREPTOCOCCUS PNEUMONIAE, IPD###	30	30	42	42	62	62	1.31	2.94	X
TOXIC SHOCK SYN	0	0	0	0	0	0	0.01	0.00
TOXIC SHOCK SYN (STREPTOCOCCAL)	.	.	.	.	6	6	0.09	0.28
TUBERCULOSIS	12	12	15	15	.	.	0.83	0.14	X
TULAREMIA	0	0	0	0	0	0	0.00	0.00
UNUSUAL ILLNESS	0	0	0	0	0	0	0.01	0.00
WEST NILE VIRUS (ENCEPHALITIS)	0	0	0	0	0	0	0.00	0.00
WEST NILE VIRUS (FEVER)	0	0	0	0	0	0	0.00	0.00

*Due to software transition STD data since 2014 are not comparable with those in previous years. Rate denominators are interpolated population estimates/projections using demographic data under ongoing revisions by the state demographer. Use of onset date in data aggregation for cases other than STD or TB (since Jan-2013) causes changes in cases reported here from previously released reports. Numbers are provisional including confirmed, probable and suspect (since Feb-08) cases. HIV/AIDS/TB case counts provided by Office of Disease Surveillance. Data suppression denoted by ‘.’ applies if number of cases <5. Quarterly disease total (excluding STD and TB cases)=879(reported total=4431). Quarterly congenital syphilis cases (suppression applied) for 2014-2016 were .,.,.(YTD totals of .,.,.) respectively.

**Reporting of novel type A influenza (reclassified as INFLU OUTBRK per CDC recommendations as of Jan-11) started in May-09.

#E. COLI O157:H7 instead of STEC was reported prior to 2006.

##Reported since Mar-07.

###S. pneumo invasive diseases (reported since Sep-05) previouly reported under separate categories grouped together as of Jan-11 per CDC recommendations.

~~Confidence intervals (not shown) for the quarterly disease incidence rates provided a basis for an informal statistical test to determine if the current quarterly rates changed significantly from those of the previous 5 years aggregated. Text in green where rates decreased and in red where rates increased. Statistically significant changes indicated by ‘X’ (rate comparisons made if 5+ cases reported in the current quarter of this year or previous 5 years aggregated).